Apimeds Pharmaceuticals US, Inc. (APUS) Q3 2024 Earnings
APUS·Reported September 30, 2024
Diluted EPS came in at $-0.03.
Diluted EPS
$-0.03
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q3 2024 Earnings FAQ
Common questions about Apimeds Pharmaceuticals US, Inc.'s Q3 2024 earnings report.
Apimeds Pharmaceuticals US, Inc. (APUS) reported Q3 2024 earnings on September 30, 2024.
Apimeds Pharmaceuticals US, Inc. reported diluted EPS of $-0.03 for Q3 2024.